comparemela.com

Latest Breaking News On - கே ஆரோக்கியம் - Page 20 : comparemela.com

2021 opens with record investments for Israeli startups

2021 opens with record investments for Israeli startups Unprecedented total of at least $1.2 billion in January includes rounds for unicorns Rapyd, K Health, OwnBackup, Melio and DriveNets. Photo by Annie Spratt on Unsplash Following a record-breaking year that saw some $10 billion of investment flowing to Israeli companies, the reported amount of funds raised in January exceeded $1.2 billion, the highest amount for a single month ever. The highest reported amount was $300 million by Rapyd, which embeds fintech services into apps, in a Series D round. Rapyd, now valued at $2.5 billion, is one of five unicorns privately held companies worth at least $1 billion that raised the majority of the January funds reported. Israel has the most unicorns per capita.

United-states
Israel
Israeli
Drivenets-network-cloud
Ok-health
K-health-of-tel-aviv
Tel-aviv
ஒன்றுபட்டது-மாநிலங்களில்
இஸ்ரேல்
இஸ்ரேலி
கே-ஆரோக்கியம்

Covid-19 vaccines: when will children be able to get them?

Covid-19 vaccines: when will children be able to get them? Covid-19 vaccines: when will children be able to get them? By Sara Goldenberg | February 2, 2021 at 8:21 PM EST - Updated February 2 at 8:21 PM CLEVELAND, Ohio (WOIO) - Top infectious disease expert Dr. Anthony Fauci predicts children could get vaccinated against Covid-19 by late spring or the summer. Fauci said vaccinating children is a necessary step to widespread immunity to the virus. Vaccines aren’t approved yet for children, but testing is currently underway for those as young as 12. Fauci said if those trials are successful, there will be another round of testing down to those nine years old.

Ohio
United-states
Cleveland
Anthony-fauci
David-shafran
Ok-health
Corona-virus
Covid-19
Vaccines
Covid-19-vaccine
Kids-covid-19-vaccine
Children-covid-19-vaccine

NYC Health Chief Infected; Astra Tackling Variants: Virus Update

California, N.Y. to Open New Stadium Vaccine Sites: Virus Update Bloomberg 2/3/2021 Bloomberg News © Bloomberg People wearing protective masks wait in line to receive a dose of the Moderna Covid-19 vaccine at a walk up vaccination site in San Francisco, California, U.S., on Wednesday, Feb. 3, 2021. (Bloomberg) AstraZeneca Plc and the University of Oxford have started looking at how to re-engineer their coronavirus vaccine to defeat new mutations, saying a tweaked injection could be ready by autumn. GlaxoSmithKline Plc agreed to work with CureVac NV to help boost production of its experimental vaccine and improve the shot to help protect against multiple variants.

Wuhan
Hubei
China
South-africa
Jiemian
Fujian
Serbia
New-york
United-states
Hong-kong
United-kingdom
Congo

N.J. Eases Dining Curbs; NYC Health Chief Infected: Virus Update

California, N.Y. to Open New Stadium Vaccine Sites: Virus Update Bloomberg 2/3/2021 Bloomberg News © Bloomberg People wearing protective masks wait in line to receive a dose of the Moderna Covid-19 vaccine at a walk up vaccination site in San Francisco, California, U.S., on Wednesday, Feb. 3, 2021. (Bloomberg) AstraZeneca Plc and the University of Oxford have started looking at how to re-engineer their coronavirus vaccine to defeat new mutations, saying a tweaked injection could be ready by autumn. GlaxoSmithKline Plc agreed to work with CureVac NV to help boost production of its experimental vaccine and improve the shot to help protect against multiple variants.

China
South-africa
Serbia
New-york
United-states
Hong-kong
United-kingdom
Congo
Beijing
Portugal
Russia
Ethiopia

Astra to Tackle Variants; Glaxo Joins CureVac: Virus Update

California, N.Y. to Open New Stadium Vaccine Sites: Virus Update Bloomberg 2/3/2021 Bloomberg News © Bloomberg People wearing protective masks wait in line to receive a dose of the Moderna Covid-19 vaccine at a walk up vaccination site in San Francisco, California, U.S., on Wednesday, Feb. 3, 2021. (Bloomberg) AstraZeneca Plc and the University of Oxford have started looking at how to re-engineer their coronavirus vaccine to defeat new mutations, saying a tweaked injection could be ready by autumn. GlaxoSmithKline Plc agreed to work with CureVac NV to help boost production of its experimental vaccine and improve the shot to help protect against multiple variants.

India
Jiemian
Fujian
China
United-kingdom
Serbia
Taiwan
Australia
Hong-kong
Paris
France-general
France

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.